Sort by: Company Name or Presentation Category

Tuesday, November 18, 2003
time	room	company	presentation category
9:40 AM	204A	TransTech Pharma, Inc.	Drug Discovery
9:40 AM	204C	BioRexis Pharmaceutical Corporation	Antibodies
9:50 AM	204A	Linguagen Corp.	Drug Discovery
9:50 AM	204C	DarPharma, Inc.	CNS/Neurology
10:00 AM	204A	Barrier Therapeutics, Inc.	Dermatology
10:00 AM	204C	EraGen Biosciences, Inc.	Diagnostics
10:10 AM	204A	Intronn Inc.	Gene/Cell Therapy
10:10 AM	204C	Aciont Inc.	Drug Delivery
10:20 AM	204A	BioVex Limited	Cancer
10:20 AM	204C	Transave, Inc.	Drug Delivery
10:30 AM	204A	Gemin X Biotechnologies Inc.	Cancer
10:30 AM	204C	Altea Therapeutics	Drug Delivery
10:40 AM	204A	Salmedix, Inc.	Cancer
10:40 AM	204C	Gel Med Sciences, Inc	Drug Delivery
10:50 AM	204A	EXIMIAS Pharmaceutical Corp.	Cancer
10:50 AM	204C	FemmePharma, Inc.	Drug Delivery
11:00 AM	204A	KeyCell Therapeutics	Cancer
11:00 AM	204C	Gelifex, Inc.	Biomaterial/Skin/Wound
11:10 AM	204A	Prestwick Pharmaceuticals, Inc.	CNS / Neurology
11:10 AM	204C	X-Ceptor Therapeutics, Inc.	Cardiovascular
11:20 AM	204A	RetinaPharma Technologies, Inc.	CNS/Neurology
11:20 AM	204C	ALung Technologies, Inc.	Cardiovascular
11:30 AM	204A	Aderis Pharmaceuticals, Inc.	CNS/Neurology
11:30 AM	204C	Eagle Vision Pharmaceutical Corp.	Cardiovascular
11:40 AM	204A	Artesian Therapeutics, Inc.	Cardiovascular
11:40 AM	204C	Fluorous Technologies Incorporated	Chemistry
2:20 PM	204A	Triad Therapeutics, Inc.	Autoimmune/Inflammation
2:20 PM	204C	Aptamera, Inc.	Cancer
2:30 PM	204A	Merrimack Pharmaceuticals, Inc.	Autoimmune/Inflammation
2:30 PM	204C	Targeted Diagnostics & Therapeutics, Inc.	Cancer
2:40 PM	204A	Phenomix Corporation	Autoimmune/Inflammation
2:40 PM	204C	Celator Technologies Inc.	Cancer
2:50 PM	204A	CombinatoRx	Drug Discovery
2:50 PM	204C	PBL Therapeutics	Cancer
3:00 PM	204A	Structural GenomiX, Inc.	Drug Discovery
3:00 PM	204C	Onconova Therapeutics Inc.	Cancer
3:10 PM	204A	Locus Pharmaceuticals, Inc.	Drug Discovery
3:10 PM	204C	Rejuvenon Corp.	Cancer
3:20 PM	204A	Norak Biosciences, Inc.	Drug Discovery
3:20 PM	204C	Alteris Therapeutics, Inc.	Cancer
3:30 PM	204A	Gryphon Therapeutics, Inc.	Drug Discovery
3:30 PM	204C	Bonecraft LLC	Musculoskeletal
3:40 PM	204A	Scion Pharmaceuticals Inc.	Drug Discovery
3:40 PM	204C	Cytokine PharmaSciences Inc.	Autoimmune/Inflammation
3:50 PM	204A	Hydra Biosciences, Inc.	Cardiovascular
3:50 PM	204C	ImmunoSite, Inc.	Autoimmune/Inflammation
4:00 PM	204A	Cardiokine Inc.	Cardiovascular
4:00 PM	204C	PhysioAdvantage LLC	Pulmonary
Wednesday, November 19, 2003
time	room	company	presentation category
9:50 AM	204A	CEPTYR, Inc.	Metabolic
9:50 AM	204C	GlycoMimetics, Inc.	Inflammation
10:00 AM	204A	Aureon Biosciences Corporation	Cancer
10:00 AM	204C	Acceptys, Inc.	Antibodies
10:10 AM	204A	EluSys Therapeutics, Inc.	Cancer
10:10 AM	204C	Bionaut Pharmaceuticals, Inc.	Enabling Technology
10:20 AM	204A	Neuronyx, Inc.	Gene/Cell Therapy
10:20 AM	204C	Revivicor, Inc.	Transplant
10:30 AM	204A	Nucleonics, Inc.	Infectious Disease
10:30 AM	204C	MaxCyte, Inc.	Gene/Cell Therapy
10:40 AM	204A	GliaMed, Inc.	CNS/Neurology
10:40 AM	204C	Acuity Pharmaceuticals	Enabling Technologies
10:50 AM	204A	PhageTech Inc.	Infectious Disease
10:50 AM	204C	Glyconix Corp.	Enabling Technology
11:00 AM	204A	Biosyn, Inc.	Infectious Diseases
11:00 AM	204C	APT Therapeutics, Inc.	Drug Discovery
11:10 AM	204A	MacroGenics, Inc.	Antibodies
11:10 AM	204C	Chaperone Technologies, Inc.	Infectious Diseases
11:20 AM	204A	RenalTech International, LLC	Renal
11:20 AM	204C	Cytochroma Inc.	Drug Discovery
11:30 AM	204A	Protein Forest, Inc.	Proteomics
11:30 AM	204C	Protez Pharmaceuticals Inc.	Infectious Diseases